BASEC ID Project title Type of project Type of clinical trial Study phase (clinical trials only) multi- / monocentric Category Principal investigator Sponsor Investigational sites Lead EC Local EC(s) Approval date Minors Study Ended
2022-01863 Zurich Infant Faces: Development of the Zurich Infant Faces Database for Neutral and Happy Faces non clinical, involving persons monocentric A Prof.Dr.med Giancarlo Natalucci University Hospital of Zurich University Hospital Zurich/ University of Zurich, Zurich
Kantonale Ethikkommission Zürich 27.01.2023 yes
2022-01862 Stationary psilocybin-assisted versus treatment as usual psychodynamic psychotherapy for treatment-resistant depression: A qualitative and observational pilot study non clinical, involving persons monocentric A PD Dr. med. Rainer Krähenmann Psychiatrische Dienste Thurgau Psychiatric Services Thurgau, Münsterlingen
Ethikkommission Ostschweiz (EKOS) 29.11.2022
2022-01861 Effect of Glyceroltrinitrate on human energy expenditure and brown adipose tissue thermogenesis clinical trial other clinical trials monocentric B PD Dr.med. Matthias J. Betz University Hospital Basel Department of Endocrinology, Diabetes and Metabolism, University Hospital Basel, Basel
Ethikkommission Nordwest- und Zentralschweiz EKNZ 03.01.2023
2022-01860 Long term outcome in adolescent and young adult treated with Ponseti manipulative technique non clinical, involving persons monocentric A Ambra Donzelli BPR CHUV, Lausanne
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 02.12.2022 yes
2022-01859 Boosting and guiding neuroplasticity by combining ketamine with neurofeedback-assisted learning – towards an individualized and integrated pharmaco-psychotherapy for cocaine addiction clinical trial drugs phase 2 monocentric B Dr. med. Marcus Herdener Psychiatrische Universitätsklinik Zürich Psychiatrische Universitätsklinik Zürich, Universität Zürich, Zürich
Kantonale Ethikkommission Zürich 06.12.2022
2022-01858 Vessel pathology and vascular-device interaction deceased persons monocentric Dr. Max Gay BIOTRONIK AG Biotronik AG, Bülach
Kantonale Ethikkommission Zürich 18.08.2023
2022-01857 Individualized cephalometry: an update of the Segner-Hasund harmony box. personal data/biological material monocentric Dr. Vasiliki Koretsi Klinik für Kieferorthopädie und Kinderzahnmedizin Klinik für Kieferorthopädie und Kinderzahnmedizin, Zürich
Kantonale Ethikkommission Zürich 18.11.2022
2022-01856 GENE MUTATIONS IN GLAUCOMA non clinical, involving persons monocentric A Mateusz Kecik University Hospitals of Geneva HUG, Geneva
Commission Cantonale d'éthique de la recherche Genève (CCER) 16.01.2023
2022-01855 REAL 8 - A study comparing the effect and safety of once weekly dosing of somapacitan with daily Norditropin® as well as evaluating long-term safety of somapacitan in a basket study design in children More ... clinical trial drugs phase 3 monocentric C Prof. Dr. med. Claudia Böttcher Novo Nordisk Pharma AG Inselspital Bern, Bern
Kantonale Ethikkommission Bern 08.02.2023 yes
2022-01854 Analysis of tumour immune contexture in untreated and post-therapy conditions personal data/biological material monocentric Dr. Karina Silina ETHZ ETHZ, Zurich
Kantonale Ethikkommission Zürich 22.11.2022
2022-01852 CoPing strategIes-psyChological flexibiliTy in patients hospitalized for ischemic cardiovascUlaR disEase - PICTURE non clinical, involving persons monocentric A Prof. Marco Valgimigli Istituto Cardiocentro Ticino Istituto Cardiocentro Ticino, Lugano
Comitato etico cantonale Ticino 09.11.2022
2022-01851 mechBRACE - Association between ACL injury and clinical, functional and biomechanical parameters across the lifespan personal data/biological material monocentric Prof. Dr. Annegret Mündermann USB USB, Basel
Ethikkommission Nordwest- und Zentralschweiz EKNZ 02.11.2022
2022-01850 Morphologische Biomarker aus der klinischen multimodalen Bildgebung und funktionelle Ergebnisse bei feuchter AMD und DME unter intravitrealer Therapie personal data/biological material monocentric Prof. Dr. med. Justus G. Garweg Berner Augenklinik Berner Augenklinik, Bern
Kantonale Ethikkommission Bern 03.02.2023 Study has ended
2022-01848 Arzneimittelexantheme unter Immuntherapien mit Checkpoint-Inhibitoren — Eine retrospektive Analyse am Luzerner Kantonsspital personal data/biological material monocentric Prof. Dr.med. Balthasar Hug Luzerner Kantonsspital Luzerner Kantonsspital, 6000 Luzern 16
Ethikkommission Nordwest- und Zentralschweiz EKNZ 08.11.2022
2022-01847 Prospective observational study on radioresistance mediated by S100A9 in patients with brain metastases non clinical, involving persons monocentric A Prof. Dr. med. Michael Weller CNIO (Centro Nacional de Investigaciones Oncológicas) University Hospital Zurich, Zurich
Kantonale Ethikkommission Zürich 27.01.2023
2022-01845 Hemithyroidectomy as Definitive Treatment in Patients with Low-Risk Thyroid Cancer personal data/biological material monocentric Dr. med. univ. Stefanie Sinz Kantonsspital St. Gallen Kantonsspital St. Gallen, St. Gallen
Ethikkommission Ostschweiz (EKOS) 20.10.2022
2022-01844 Engineering Human Lactation from Micro To Macro Scale personal data/biological material multicentric Prof. Dr. Marcy Zenobi-Wong ETH Zürich ETH Zürich, Zürich
Biesegen Plastic Surgery, Zürich
Kantonale Ethikkommission Zürich Kantonale Ethikkommission Zürich 18.11.2022
2022-01843 Impact de la glycémie préhospitalière sur le pronostic des patients pris en charge en préhospitalier pour une douleur thoracique personal data/biological material monocentric Karim Gariani Geneva University Hospitals Service d’Endocrinologie, Diabétologie, Nutrition et Education thérapeutique du patient Département de médecine, Geneva
Commission Cantonale d'éthique de la recherche Genève (CCER) 16.02.2023
2022-01842 Define the impact of CD4+/CD8+ T-cells on retinal degeneration in humans / Definition des Einflusses von CD4+/CD8+ T-Zellen auf humane Retinadegenerationen personal data/biological material monocentric Prof. Volker Enzmann Inselspital Inselspital, Bern
Kantonale Ethikkommission Bern 31.01.2023
2022-01841 GS-US-590-6154 (ENHANCE 3): A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Magrolimab versus Placebo in Combination with Venetoclax and Azacitidine More ... clinical trial drugs phase 3 multicentric C Prof. Dr. med. / Thomas / Pabst Gilead Sciences, Inc. Inselspital, Bern
USZ, Klinik für Medizinische Onkologie und Hämatologie, Zürich
Kantonale Ethikkommission Bern Kantonale Ethikkommission Zürich 21.02.2023 Study has ended